Lipidomic Signatures Informs Intravenous Racemic Ketamine Associated Remission in Treatment-Resistant Depression: A Pilot Study

被引：0
|
作者：
Singh, Balwinder [1 ]
MahmoudianDehkordi, Siamak [1 ]
Voort, Jennifer Vande [1 ]
Han, Xianlin [1 ]
Port, John [1 ]
Frye, Mark [1 ]
Daouk, Rima Kaddurah [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2022年 / 47卷
关键词：
IV; Ketamine; Metabolomics Signature; Treatment; Resistant Depression; Open Label Trials;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P227
引用
收藏
页码：192 / 192
页数：1
相关论文
共 50 条
  • [21] Intravenous arketamine for treatment-resistant depression: open-label pilot study
    Gustavo C. Leal
    Igor D. Bandeira
    Fernanda S. Correia-Melo
    Manuela Telles
    Rodrigo P. Mello
    Flavia Vieira
    Cassio S. Lima
    Ana Paula Jesus-Nunes
    Lívia N. F. Guerreiro-Costa
    Roberta F. Marback
    Ana Teresa Caliman-Fontes
    Breno L. S. Marques
    Marília L. O. Bezerra
    Alberto L. Dias-Neto
    Samantha S. Silva
    Aline S. Sampaio
    Gerard Sanacora
    Gustavo Turecki
    Colleen Loo
    Acioly L. T. Lacerda
    Lucas C. Quarantini
    European Archives of Psychiatry and Clinical Neuroscience, 2021, 271 : 577 - 582
  • [22] Intravenous arketamine for treatment-resistant depression: open-label pilot study
    Leal, Gustavo C.
    Bandeira, Igor D.
    Correia-Melo, Fernanda S.
    Telles, Manuela
    Mello, Rodrigo P.
    Vieira, Flavia
    Lima, Cassio S.
    Jesus-Nunes, Ana Paula
    Guerreiro-Costa, Livia N. F.
    Marback, Roberta F.
    Caliman-Fontes, Ana Teresa
    Marques, Breno L. S.
    Bezerra, Marilia L. O.
    Dias-Neto, Alberto L.
    Silva, Samantha S.
    Sampaio, Aline S.
    Sanacora, Gerard
    Turecki, Gustavo
    Loo, Colleen
    Lacerda, Acioly L. T.
    Quarantini, Lucas C.
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2021, 271 (03) : 577 - 582
  • [23] Intranasal Ketamine in Treatment-resistant Depression
    Lapidus, Kyle A.
    Levitch, Cara F.
    Soleimani, Laili
    Perez, Andrew M.
    Brallier, Jess W.
    Parides, Michael K.
    Iosifescu, Dan V.
    Charney, Dennis S.
    Murrough, James W.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S361 - S361
  • [24] Propofol for Treatment-Resistant Depression: A Pilot Study
    Mickey, Brian J.
    White, Andrea T.
    Arp, Anna M.
    Leonardi, Kolby
    Torres, Marina M.
    Larson, Adam L.
    Odell, David H.
    Whittingham, Sara A.
    Beck, Michael M.
    Jessop, Jacob E.
    Sakata, Derek J.
    Bushnell, Lowry A.
    Pierson, Matthew D.
    Solzbacher, Daniela
    Kendrick, E. Jeremy
    Weeks, Howard R., III
    Light, Alan R.
    Light, Kathleen C.
    Tadler, Scott C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2018, 21 (12) : 1079 - 1089
  • [25] Effect of intravenous ketamine on suicidality in adults with treatment-resistant depression: A real world effectiveness study
    Chen-Li, David C. J.
    Mansur, Rodrigo B.
    Di Vincenzo, Joshua D.
    Chisamore, Noah
    Kaczmarek, Erica
    Mcintyre, Roger S.
    Rosenblat, Joshua D.
    PSYCHIATRY RESEARCH, 2025, 343
  • [26] Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression
    Salloum, Naji C.
    Fava, Maurizio
    Freeman, Marlene P.
    Flynn, Martina
    Hoeppner, Bettina
    Hock, Rebecca S.
    Cusin, Cristina
    Iosifescu, Dan V.
    Trivedi, Madhukar H.
    Sanacora, Gerard
    Mathew, Sanjay J.
    Debattista, Charles
    Ionescu, Dawn F.
    Papakostas, George I.
    DEPRESSION AND ANXIETY, 2019, 36 (03) : 235 - 243
  • [27] Intravenous subanesthetic ketamine: an innovative treatment option for rapid response in treatment-resistant depression
    Kang, M.
    Hawken, E.
    Bahji, A.
    Brietzke, E.
    Vazquez, G.
    EUROPEAN PSYCHIATRY, 2020, 63 : S113 - S113
  • [28] Effects of Repeated Intravenous Ketamine in Treatment-Resistant Geriatric Depression A Case Series
    Bryant, Kelly A.
    Altinay, Murat
    Finnegan, Nora
    Cromer, Kim
    Dale, Roman M.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (02) : 158 - 161
  • [29] Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
    Price, Rebecca B.
    Nock, Matthew K.
    Charney, Dennis S.
    Mathew, Sanjay J.
    BIOLOGICAL PSYCHIATRY, 2009, 66 (05) : 522 - 526
  • [30] Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
    aan het Rot, Marije
    Collins, Katherine A.
    Murrough, James W.
    Perez, Andrew M.
    Reich, David L.
    Charney, Dennis S.
    Mathew, Sanjay J.
    BIOLOGICAL PSYCHIATRY, 2010, 67 (02) : 139 - 145
12345